Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-15-000724
Filing Date
2015-02-05
Accepted
2015-02-05 11:43:40
Documents
9
Period of Report
2014-11-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1114_il2minternational.htm 10-Q 463719
2 CERTIFICATION f10q1114ex31i_il2mintl.htm EX-31.1 11760
3 CERTIFICATION f10q1114ex32i_il2mintl.htm EX-32.1 4734
  Complete submission text file 0001213900-15-000724.txt   3887096

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE dynh-20141130.xml EX-101.INS 434616
5 XBRL SCHEMA FILE dynh-20141130.xsd EX-101.SCH 34247
6 XBRL CALCULATION FILE dynh-20141130_cal.xml EX-101.CAL 29953
7 XBRL DEFINITION FILE dynh-20141130_def.xml EX-101.DEF 104995
8 XBRL LABEL FILE dynh-20141130_lab.xml EX-101.LAB 294562
9 XBRL PRESENTATION FILE dynh-20141130_pre.xml EX-101.PRE 217180
Mailing Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505
Business Address 3500 WEST OLIVE AVENUE SUITE 810 BURBANK CA 91505 818-953-7585
il2m INTERNATIONAL CORP. (Filer) CIK: 0001520512 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-176587 | Film No.: 15578770
SIC: 2834 Pharmaceutical Preparations